- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:58 | FDA starts review of Sanofi's MS hope tolebrutinib | ||
| 13:58 | GSK taps into UK health data for dementia study | ||
| 11:59 | Trump nominates Susan Monarez as CDC director | ||
| 10:58 | AbbVie sues Genmab, claiming trade secrets theft | ||
| Mo | MIT team develops 'years-long' drug delivery tech | ||
| Mo | Novo Nordisk looks east for another obesity therapy | ||
| Mo | Phase 3 readout puts Opthea at risk of insolvency | ||
| Mo | Augustine decloaks with $85m for nerve disease programme | ||
| Mo | 23andMe files for bankruptcy protection | ||
| Fr | EMA panel endorses AI for MASH clinical trials | ||
| Fr | AZ builds in China, as J&J ramps up its US investments | ||
| Fr | Fabhalta is first FDA-approved therapy for rare disease C3G | ||
| Fr | J&J adds to IL-23 options in Crohn's after FDA approval | ||
| Fr | Alnylam joins three-way contest in ATTR cardiomyopathy | ||
| Do | Synchron, Nvidia showcase AI for brain-computer interfaces | ||
| Do | CARGO offloads staff after abandoning lead CAR-T | ||
| Do | Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug | ||
| Do | Gantenerumab 'shows sign of preventing Alzheimer's dementia' | ||
| Do | UK is becoming an 'outlier' for pharma, hitting investment | ||
| Mi | Roche taps Oxford BioTherapeutics for cancer drug discovery | ||
| Mi | Google promises new AI models for drug discovery | ||
| Mi | J&J's nipocalimab fast-tracked for Sjogren's disease | ||
| Mi | Sarepta slumps on Elevidys patient death | ||
| Mi | Novartis sheds staff as Entresto patent expiry looms | ||
| 18.03. | EnteroBiotix cues up larger trial of microbiome IBS therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
